Search

You searched for "cystotomies"

80 results found

Occupational tumours of the urinary tract: The work of Denis Poole-Wilson

1 July 2017 | | URO - Technology, URO - Urologic Oncology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would be taking you to the...

David Newman

1 May 2017 | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would write on a Scottish theme...

Infections and inflammation: Part 2

1 March 2019 | URO - Infection, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
See also Part 1 and Part 3. Case 1 A 43-year-old lady presented to the urologist with a history of pain during bladder filling and associated frequency / urgency. She underwent standard microbiological and radiological investigations that are normal. She...

From Peyronie to Foley: the backstories behind the urology legends

4 November 2025 | | URO - Technology
Eponyms play a significant role in the field of urology, serving as a bridge between historical medical discoveries and modern clinical practice. For urology trainees, understanding these eponyms is more than just memorising names; it enriches our grasp of key...

Post-orgasmic illness syndrome

1 May 2017 | | URO - Andrology
Introduction Disorders of ejaculation are a rare and poorly understood subsection of male sexual dysfunction. A paucity of evidence has hindered advances in definitions, epidemiology, pathophysiology and management. The licensing of a specific medication for premature ejaculation signalled the research...

Urethroplasty: a review of indications, techniques and outcomes

1 March 2018 | | URO - Functional / Reconstructive Urology
Urethral stricture is the most common cause of lower urinary tract obstruction in men aged between 20 and 40, carrying an estimated overall prevalence of 0.5% in the UK [1] and results in around 17,000 hospital admissions annually [2]. Endoscopic...

Ketamine uropathy – an update

29 January 2020 | | URO - Functional / Reconstructive Urology
The first two case series that documented the association between urinary tract damage and recreational ketamine use were published 12 years ago [1,2]. Since then ketamine has maintained a controversial profile as an essential medication of expanding utility but with...

The value of Urolink: an OOPE experience

1 May 2019 | | URO - Core Urology
I was fortunate enough to be able to take some time out of my training after ST5 to pursue an Out Of Programme Experience (OOPE) year. During the Urolink meeting at the British Association of Urological Surgeons (BAUS) 2017 conference...

Bladder cancer – an overshadowed ‘volcano’

1 May 2015 | | URO - Urologic Oncology
Bladder cancer has often been overshadowed by the limelight of prostate cancer. However, of all the urological cancers, bladder cancer is the only one which has shown a slight decline in age-standardised five-year survival rates over the last couple of...

What is new in lasers for endourology: looking into the future

7 January 2021 | | URO - Endourology & Stones, URO - Technology
From the first cystoscopic argon and neodymium-YAG (yttrium-aluminium-garnet) laser used for bladder tumours in 1976 by Staehler et al. [1], lasers have proven to be a versatile and an evolving tool in the therapeutic management of a variety of urological...

In conversation with Matthew Bultitude

27 November 2025 | URO - Core Urology
Matthew Bultitude. Can you tell us a little bit about what led you into the field of urology and what have been the highlights so far? Thank you and that is a very interesting question given that my father was...

Bladder cancer: where are we with intravesical therapies?

1 July 2016 | | URO - Urologic Oncology
In the United Kingdom, almost 10,500 new cases of bladder cancer were identified in 2013, with over 5000 deaths in 2012 [1]. Seventy percent of new cases will be non-muscle invasive bladder cancer (NMIBC) at diagnosis and therefore will be...